FOLH1 and cancer: For diagnosis of cancer of any grade or length, sensitivity with the E-PSMA Likert system reduced to 0.79 (95% CI: 0.67–0.90), comparable to the PRIMARY system (0.74; 95% CI: 0.61–0.86; P = 0.1).